Skip to main content

Advertisement

SpringerLink
Log in

E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells

  • Original Paper
  • Published:
Cellular Oncology Aims and scope Submit manuscript

Abstract

Purpose

We and others show that SOSTDC1 is down-regulated in breast cancer tissues compared to matched normal tissues. Previously, we found that epigenetic mechanisms underlie the down-regulation of SOSTDC1 in gastric cancer cells. The aim of this study was to assess the putative epigenetic regulation of SOSTDC1 expression in breast cancer cells.

Methods

Microarray-based expression profiling was performed in a series of primary breast cancers and matched normal tissues. Real-time PCR was performed to assess SOSTDC1 and E4BP4 mRNA levels in MCF7, BT549, MBMDA231, T47D (breast cancer) and HEK293T (normal kidney) cell lines. Methylation-specific PCR (MSP) and bisulfite sequencing PCR (BSP) were performed to assess the methylation level of the SOSTDC1 gene promoter, and 5-Aza 2-deoxycytidine (5'-Aza-dC) treatment was used to induce its demethylation. A luciferase assay was used to measure SOSTDC1 promoter activity in vitro. Stable shRNA-mediated knockdown of E4BP4 was carried out in MCF7 cells and confirmed by Western blotting. Finally, MCF7 cell proliferation and survival were measured by MTS assay.

Results

We found that SOSTDC1 is frequently down-regulated in primary breast cancers (98.2 %) and in all breast cancer cell lines tested. MSP and BSP analyses revealed SOSTC1 promoter hypermethylation at CpG sites. 5'-Aza-dC treatment induced a striking down-regulation of SOSTDC1 gene expression, whereas BSP analysis showed demethylation of its promoter. Subsequent in silico SOSTDC1 promoter analysis indicated the presence of putative transcriptional repressor E4BP4 binding sites, and promoter deletion studies indeed revealed repressor binding regions encompassing these E4BP4 binding sites. Relative quantification of E4BP4 expression showed an inverse correlation to SOSTDC1 expression in the breast cancer cell lines tested. Exogenous over-expression of E4BP4 in HEK-293 and BT549 cells reduced SOSTDC1 expression and its promoter activity, respectively. Stable shRNA-mediated E4BP4 BT549 and MCF7 knock-down cells treated with 5'-Aza-dC exhibited up-regulation of SOSTDC1 expression and a concomitant inhibition of cell proliferation and survival.

Conclusion

From our results we conclude that the transcriptional repressor E4BP4 plays a role in repressing epigenetically regulated SOSTDC1 expression in breast cancer cells, which can be reverted by E4BP4 silencing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. S. Tabarestani, S.M. Ghaderian, H. Rezvani, R. Mirfakhraie, A. Ebrahimi, H. Attarian, J. Rafat, M. Ghadyani, H.A. Alavi, N. Kamalian, A. Rakhsha, E. Azargashb, Prognostic and predictive value of copy number alterations in invasive breast cancer as determined by multiplex ligation-dependent probe amplification. Cell. Oncol. 37, 107–118 (2014)

    Article  CAS  Google Scholar 

  2. A. Rawat, G. Gopal, G. Selvaluxmy, T. Rajkumar, Inhibition of ubiquitin conjugating enzyme UBE2C reduces proliferation and sensitizes breast cancer cells to radiation, doxorubicin, tamoxifen and letrozole. Cell. Oncol. 36, 459–67 (2013)

    Article  CAS  Google Scholar 

  3. A. Geurts van Kessel, The cancer genome: from structure to function. Cell. Oncol. 37, 155–165 (2014)

  4. J.S. de Groot, X. Pan, J. Meeldijk, E. van der Wall, P.J. van Diest, C.B. Moelans, Validation of DNA promoter hypermethylation biomarkers in breast cancer–a short report. Cell. Oncol. 37, 297–303 (2014)

    Article  Google Scholar 

  5. E. Dulaimi, J. Hillinck, I. de Caceres Ibanez, T. Al-Saleem, P. Cairns, Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Clin. Cancer Res. 10, 6189–6193 (2004)

    Article  CAS  PubMed  Google Scholar 

  6. X. Yang, L. Yan, N.E. Davidson, DNA methylation in breast cancer. Endocr Relat Cancer. 8, 115–127 (2001)

    Article  CAS  PubMed  Google Scholar 

  7. T.X. Xiang, Y. Yuan, L. Li, Z.H. Wang, L.Y. Dan, G.S. Chen Ren, Q. Tao, Aberrant promoter CpG methylation and its translational applications in breast cancer. Chin J Cancer. 30, 12–20 (2013)

    Article  Google Scholar 

  8. K.A. Clausen, K.R. Blish, C.E. Birse, M.A. Triplette, T.E. Kute, G.B. Russell, R.B. D’Agostino Jr., L.D. Miller, F.M. Torti, S.V. Torti, SOSTDC1 differentially modulates Smad and beta–catenin activation and is down–regulated in breast cancer. Breast Cancer Res. Treat. 129, 737–746 (2010)

    Article  PubMed Central  PubMed  Google Scholar 

  9. K.R. Blish, W. Wang, W.M.C. Du, C.E. Birse et al., A human bone morphogenetic protein antagonist is down-regulated in renal cancer. Mol. Biol. Cell 19, 457–464 (2008)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. G. Gopal, U.M. Raja, S. Shirley, K.R. Rajalekshmi, T. Rajkumar, SOSTDC1 down-regulation of expression involves CpG methylation and is a potential prognostic marker in gastric cancer. Cancer Genet. 206, 174–182 (2013)

    Article  CAS  PubMed  Google Scholar 

  11. I.G. Cowell, H.C. Hurst, Protein-protein interaction between the transcriptional repressor E4BP4 and the TBP-binding protein Dr1. Nucleic Acids Res. 24, 3607–3613 (1996)

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  12. I.G. Cowell, A. Skinner, H.C. Hurst, Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol. Cell. Biol. 12, 3070–3077 (1992)

    CAS  PubMed Central  PubMed  Google Scholar 

  13. T. Rajkumar, N. Vijayalakshmi, G. Gopal, K. Sabitha, S. Shirley, U.M. Raja, S.A. Ramakrishnan, Identification and validation of genes involved in gastric tumorigenesis. Cancer Cell Int. 10(45), 1475–2867 (2010). 10-45

    Google Scholar 

  14. S. Ammanamanchi, M.G. Brattain, Sp3 is a transcriptional repressor of transforming growth factor-beta receptors. J. Biol. Chem. 276, 3348–3352 (2001)

    Article  CAS  PubMed  Google Scholar 

  15. N.H. Nabilsi, R.R. Broaddus, D.S. Loose, DNA methylation inhibits p53-mediated survivin repression. Oncogene 28, 2046–2050 (2009)

    Article  CAS  PubMed  Google Scholar 

  16. I.G. Cowell, E4BP4/NFIL3, a PAR-related bZIP factor with many roles. Bioessays 24, 1023–1029 (2002)

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded by the Department of Science and Technology, Government of India.

Conflict of interest

We declare that we have no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Molecular Oncology, Cancer Institute (WIA), 38, Sardar Patel Road, Chennai, 600036, India

    Akhilesh Rawat, Gopal Gopisetty & Rajkumar Thangarajan

Authors
  1. Akhilesh Rawat
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gopal Gopisetty
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rajkumar Thangarajan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rajkumar Thangarajan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rawat, A., Gopisetty, G. & Thangarajan, R. E4BP4 is a repressor of epigenetically regulated SOSTDC1 expression in breast cancer cells. Cell Oncol. 37, 409–419 (2014). https://doi.org/10.1007/s13402-014-0204-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13402-014-0204-6

Keywords

Search

Navigation